Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source: Secondary Analysis of a Randomized Clinical Trial (Jul, 10.1001/jamaneurol.2020.1995, 2020)

被引：1
|
作者：
Veltkamp, R.
Pearce, L. A.
Korompoki, E.
机构：
来源：
JAMA NEUROLOGY | 2020年 / 77卷 / 10期
关键词：
D O I：
10.1001/jamaneurol.2020.3444
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1322 / 1322
页数：1
相关论文
共 30 条
  • [1] Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source Secondary Analysis of a Randomized Clinical Trial
    Veltkamp, Roland
    Pearce, Lesly A.
    Korompoki, Eleni
    Sharma, Mukul
    Kasner, Scott E.
    Toni, Danilo
    Ameriso, Sebastian F.
    Mundl, Hardi
    Tatlisumak, Turgut
    Hankey, Graeme J.
    Lindgren, Arne
    Berkowitz, Scott D.
    Arauz, Antonio
    Ozturk, Serefnur
    Muir, Keith W.
    Chamorro, Angel
    Perera, Kanjana
    Shuaib, Ashfaq
    Rudilosso, Salvatore
    Shoamanesh, Ashkan
    Connolly, Stuart J.
    Hart, Robert G.
    JAMA NEUROLOGY, 2020, 77 (10) : 1233 - 1240
  • [2] Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Randomized Clinical Trial (Oct, 10.1001/jamaneurol.2020.3836, 2020)
    Shoamanesh, A.
    Hart, R. G.
    Connolly, S. J.
    JAMA NEUROLOGY, 2021, 78 (01) : 120 - 120
  • [3] Ticagrelor added to aspirin in acute ischemic stroke or transient ischemic attack in prevention of disabling stroke: a randomized clinical trial (Nov, 10.1001/jamaneurol.2020.4396, 2020)
    Amarenco, P.
    Denison, H.
    Evans, S. R.
    JAMA NEUROLOGY, 2021, 78 (02) : 253 - 253
  • [4] Predictors of Recurrent Stroke After Embolic Stroke of Undetermined Source in the RE-SPECT ESUS Trial
    Del Brutto, Victor J.
    Diener, Han-Christoph
    Easton, J. Donald
    Granger, Christopher B.
    Cronin, Lisa
    Kleine, Eva
    Grauer, Claudia
    Brueckmann, Martina
    Toyoda, Kazunori
    Schellinger, Peter D.
    Lyrer, Philippe
    Molina, Carlos A.
    Chutinet, Aurauma
    Bladin, Christopher F.
    Estol, Conrado J.
    Sacco, Ralph L.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (11):
  • [5] Apixaban for treatment of embolic stroke of undetermined source (ATTICUS) randomized trial - update of patient characteristics and study timeline after interim analysis
    Poli, S.
    Meissner, C.
    Baezner, H. J.
    Kraft, A.
    Hillenbrand, F.
    Hobohm, C.
    Liman, J.
    Wachter, R.
    Kimmig, H.
    Huber, R.
    Lindner, A.
    Althaus, K.
    Gawaz, M.
    Ziemann, U.
    Geisler, T.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2070 - 2070
  • [6] Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source An Exploratory Analysis of the NAVIGATE ESUS Randomized Clinical Trial
    Shoamanesh, Ashkan
    Hart, Robert G.
    Connolly, Stuart J.
    Kasner, Scott E.
    Smith, Eric E.
    Marti-Fabregas, Joan
    Liu, Yan Yun
    Uchiyama, Shinichiro
    Mikulik, Robert
    Veltkamp, Roland
    O'Donnell, Martin J.
    Ntaios, George
    Muir, Keith W.
    Field, Thalia S.
    Santo, Gustavo C.
    Olavarria, Veronica
    Mundl, Hardi
    Lutsep, Helmi
    Berkowitz, Scott D.
    Sharma, Mukul
    JAMA NEUROLOGY, 2021, 78 (01) : 11 - 20
  • [7] Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial
    Hart, Robert G.
    Sharma, Mukul
    Mundl, Hardi
    Shoamanesh, Ashkan
    Kasner, Scott E.
    Berkowitz, Scott D.
    Pare, Guillaume
    Kirsch, Bodo
    Pogue, Janice
    Pater, Calin
    Peters, Gary
    Davalos, Antoni
    Lang, Wilfried
    Wang, Yongjun
    Wang, Yilong
    Cunha, Luis
    Eckstein, Jens
    Tatlisumak, Turgut
    Shamalov, Nikolay
    Mikulik, Robert
    Lavados, Pablo
    Hankey, Graeme J.
    Czlonkowska, Anna
    Toni, Danilo
    Ameriso, Sebastian F.
    Gagliardi, Rubens J.
    Amarenco, Pierre
    Bereczki, Daniel
    Uchiyama, Shinichiro
    Lindgren, Arne
    Endres, Matthias
    Brouns, Raf
    Yoon, Byung-Woo
    Ntaios, George
    Veltkamp, Roland
    Muir, Keith W.
    Ozturk, Serefnur
    Arauz, Antonio
    Bornstein, Natan
    Bryer, Alan
    O'Donnell, Martin J.
    Weitz, Jeffrey
    Peacock, Frank
    Themeles, Ellison
    Connolly, Stuart J.
    EUROPEAN STROKE JOURNAL, 2016, 1 (03) : 146 - 154
  • [8] APIXABAN FOR TREATMENT OF EMBOLIC STROKE OF UNDETERMINED SOURCE -ATTICUS RANDOMIZED TRIAL- UPDATE OF PATIENT CHARACTERISTICS AND STUDY TIMELINE AFTER INTERIM ANALYSIS
    Poli, S.
    Meisner, C.
    Mengel, A.
    Baetzner, H.
    Wolf, M.
    Kraft, A.
    Hoffmann, F.
    Hillenbrand, F.
    Niehaus, L.
    Hobohm, C.
    Liman, J.
    Wachter, R.
    Kimmig, H.
    Jung, W.
    Huber, R.
    Lindner, A.
    Althaus, K.
    Meyne, J.
    Schabet, M.
    Petzold, G.
    Brachmann, J.
    Ebinger, M.
    Gawaz, M.
    Ziemann, U.
    Geisler, T.
    INTERNATIONAL JOURNAL OF STROKE, 2021, 16 (2_SUPPL) : 43 - 43
  • [9] Pioglitazone therapy in patients with stroke and prediabetes: a post hoc analysis of the IRIS randomized clinical trial (February, 10.1001/jamaneurol.2019.0079, 2019)
    Spence, J. D.
    Viscoli, C. M.
    Inzucchi, S. E.
    JAMA NEUROLOGY, 2019, 76 (05) : 625 - 626
  • [10] Dual Antiplatelet Therapy After Embolic Stroke of Undetermined Source: A Subgroup Analysis of the CHANCE-2 Trial
    Xie, Xuewei
    Jing, Jing
    Meng, Xia
    Johnston, S. Claiborne
    Bath, Philip M.
    Li, Zixiao
    Zhao, Xingquan
    Wang, Yilong
    Xu, Qin
    Wang, Anxin
    Jiang, Yong
    Li, Hao
    Wang, Yongjun
    STROKE, 2024, 55 (07) : 1739 - 1747
123